THE Federal Government has announced a major funding boost to support research into rare cancers as part of its $20 billion Medical Research Future Fund commitment.
Brain cancer disproportionally affects young people, killing more people under 25 years in Australia than any other cancer, and new genetic testing that aims to transform brain tumour classification, treatment and ultimately survival, will become available to children with brain cancer, effective 31 Oct.
AIM BRAIN is a four-year study, part of $79 million for cancer research, giving Australian children access to international research collaborations of paediatric brain cancer led by the Australian New Zealand Children's Haematology and Oncology Group, and will also be co-funded by the Robert Connor Dawes Foundation.
In addition, $13 million is now available for competitive research grants from the Medical Research Future Fund, designed to boost clinical trial and registry activity with priority given to under-researched health priorities, such as rare cancers and rare diseases.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Aug 17
